3B BlackBio Dx Ltd — Important, 30-05-2026: Company Update

3B BlackBio Dx Limited has informed stakeholders about the submission of its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. These key financial statements were formally approved by the Board of Directors during a meeting on May 29, 2026. This release provides investors with the essential performance data, offering transparency into the company's operational and financial health for the recently concluded fiscal period. Shareholders can now access the full financial details.